Skip to content

CMO Login
Collaborators Login

Home
Who We Are
- About Us
What We Do
- Programs & Services
- Technologies
News
Contact Us

Cerveau Technologies, Inc. Announces Collaboration with NYU Langone Medical Center

Posted on June 26, 2017May 25, 2020 by dev_team

Posted in PRESS RELEASE

Post navigation

Previous: Cerveau Technologies, Inc. Announces FDA Acceptance of Investigational New Drug (IND) for Tau Imaging Agent MK-6240

Next: Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search for:

Recent Posts

New PET imaging tracer helps spot signs of Alzheimer’s disease years before symptoms appear
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Cerveau Technologies, Inc. announces Formation of Scientific Advisory Board
Cerveau Scientific Advisory Board Virtual Conference 2020
Cerveau Technologies, Inc. Announces Collaboration with University College of London

Recent Comments

Archives

June 2021
September 2020
May 2020
March 2020
December 2019
November 2019
September 2019
May 2019
March 2019
February 2019
December 2018
September 2018
August 2018
June 2018
May 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
June 2017
May 2017
March 2017
February 2017
January 2017

Categories

PRESS RELEASE

Meta

Log in
Entries feed
Comments feed
WordPress.org

308 N. Peters Road Suite #201
Knoxville, TN 37922

info@cerveautechnologies.com

© Copyright 2022 Cerveau Technologies. All Rights Reserved.

Technology Web Design by Thomas Digital

Home
Who We Are
- About Us
What We Do
- Programs & Services
- Technologies
News
Contact Us